Dr. Lal Path Labs · NSE: LALPATHLAB · BSE: 539524
Q4 FY23 results · Jan–Mar 2023
Dr. Lal Path Labs reported revenue from operations of ₹491.00 crore (up 1.1% from Q4 FY22) and net profit of ₹56.90 crore (down 8.4% from Q4 FY22) for Q4 FY23 (Jan–Mar 2023), on a consolidated basis.
| Item | Q4 FY23 | Q4 FY22 | YoY | Q3 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 491.00 | 485.50 | +1.1% | 489.40 | +0.3% |
| Other income | 14.20 | 12.00 | +18.3% | 10.50 | +35.2% |
| Total income | 505.20 | 497.50 | +1.5% | 499.90 | +1.1% |
| Profit before tax | 83.20 | 83.50 | −0.4% | 76.50 | +8.8% |
| Net profit for the period | 56.90 | 62.10 | −8.4% | 53.60 | +6.2% |
| Attributable to shareholders of the company | 56.70 | 61.30 | −7.5% | 52.80 | +7.4% |
| EPS, basic (₹) | 6.84 | 7.41 | −7.7% | 6.37 | +7.4% |
| Net margin (%) | 11.6 | 12.8 | 11.0 |
| Item | Q4 FY23 | Q4 FY22 | YoY | Q3 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 431.00 | 414.90 | +3.9% | 428.40 | +0.6% |
| Other income | 11.60 | 12.90 | −10.1% | 8.60 | +34.9% |
| Total income | 442.60 | 427.80 | +3.5% | 437.00 | +1.3% |
| Profit before tax | 98.10 | 85.10 | +15.3% | 84.10 | +16.6% |
| Net profit for the period | 71.40 | 65.20 | +9.5% | 62.40 | +14.4% |
| EPS, basic (₹) | 8.61 | 7.88 | +9.3% | 7.53 | +14.3% |
| Net margin (%) | 16.6 | 15.7 | 14.6 |
Consolidated
- Filed with BSE
- 12 May 2023, 16:11 IST
- Board meeting
- 11 May 2023
- Period
- 01 Jan 2023 to 31 Mar 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 12 May 2023, 16:11 IST
- Board meeting
- 11 May 2023
- Period
- 01 Jan 2023 to 31 Mar 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE